Is Demodex the Missing Link in MGD?
Join Drs. Mile Brujic and Laura M. Periman as they provide insights into the link between Demodex blepharitis and meibomian gland dysfunction (MGD).
New Content
OD's Guide to Diagnosing and Managing Stage 1 to 3 Neurotrophic Keratitis with Cheat Sheet
Utilizing Technology to Pick the Right Lens
Join Dr. Tanner Ferguson to review key considerations for matching patients with the ideal intraocular lens (IOL) for their lifestyle needs and anatomy.
Beyond Compounding: An FDA-Approved Bevacizumab Option for Wet AMD
Join Rishi P. Singh, MD, FASRS and Bob Jahr of Outlook Therapeutics as they discuss the FDA approval of bevacizumab.
Is Demodex the Missing Link in MGD?
Join Drs. Mile Brujic and Laura M. Periman as they provide insights into the link between Demodex blepharitis and meibomian gland dysfunction (MGD).
Topics
$1 or Mystery Gift - Myopia Myths Edition
Extended Parameters in Practice: My Workflow for Expanding Contact Lens Access
Realities of Inherited Retinal Disease: Patient Perspectives and Pearls
Emerging Therapies and Clinical Trials in Early Diabetic Retinopathy
Spot the subtle signs of mild NPDR sooner, stage it with confidence, and know when watching and waiting stops serving your diabetic patients.
New data supports omega-3s for glaucoma in DED patients
Patients had roughly half the 5-year risk of developing glaucoma, though investigators stop short of claiming cause and effect.
Aldeyra to formally appeal third reproxalap CRL
Company to submit a formal dispute resolution request following Type A and D meetings with FDA over the investigational DED drop.
Merck releases phase 2b/3 wet AMD data for tri-specific antibody
Topline data demonstrates non-inferiority and higher rates of two AEs and treatment discontinuation due to AEs.
OD's Guide to Diagnosing and Managing Stage 1 to 3 Neurotrophic Keratitis with Cheat Sheet
Learn how optometrists can identify and manage stage 1 to 3 neurotrophic keratitis and download the cheat sheet for quick reference!
Glaucoma Patients Lost To Follow-Up
Join Drs. Preeya K. Gupta and Andrew Williams as they discuss the factors that lead to patients being lost to follow-up and explore strategies to improve compliance and adherence.
Utilizing Technology to Pick the Right Lens
Join Dr. Tanner Ferguson to review key considerations for matching patients with the ideal intraocular lens (IOL) for their lifestyle needs and anatomy.
Clinical Specialties
Beyond Compounding: An FDA-Approved Bevacizumab Option for Wet AMD
Is Demodex the Missing Link in MGD?
$1 or Mystery Gift - Myopia Myths Edition
Beyond the Sales Rep: Understanding Who’s Who in Industry
Discover who does what inside industry and how knowing the differences can save you time, find research opportunities, address insurance issues, and more.
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.
Utilizing AI to Increase Eyecare Practice Efficiency
Discover artificial intelligence (AI)-based platforms that eyecare providers can use to solve workflow problems to improve practice efficiency.
Careers
The Ultimate Guide to Starting a Dry Eye Practice with Check List
Glaucoma Patients Lost To Follow-Up
Join Drs. Preeya K. Gupta and Andrew Williams as they discuss the factors that lead to patients being lost to follow-up and explore strategies to improve compliance and adherence.
